Bryan Bryson: Engineering solutions to the tough problem of tuberculosis
By analyzing how Myobacterium tuberculosis interacts with the immune system, the associate professor hopes to find new vaccine targets to help eliminate the disease.
By analyzing how Myobacterium tuberculosis interacts with the immune system, the associate professor hopes to find new vaccine targets to help eliminate the disease.
The MIT senior will spend the 2026-27 year at Tsinghua University in Beijing, studying global affairs.
The program recognizes outstanding mentorship of graduate students.
The MIT senior helps design proteins that spur the immune system to fight cancer and other diseases.
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination.
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
With its circular single-stranded DNA molecules, MIT spinout Kano Therapeutics plans to make gene and cell therapies safer and more effective.
A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.
Inspired by traditional acupuncture, the approach has potential to impact all implantable bioelectronic devices, enabling applications such as hypertension mitigation.
Vivian Chinoda ’25, Alice Hall, Sofia Lara, and Sophia Wang ’24 will begin postgraduate studies at Oxford University next fall.
MIT.nano cleanroom complex named after Robert Noyce PhD ’53 at the 2025 Nano Summit.
Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.
Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.